Overview

Topical Corticosteroids Market is forecasted to value over USD 5.1 billion by 2027 end and register a CAGR of 5.7% from the forecast period 2020-2027.

FutureWise Market Research has illustrated a report on the Topical Corticosteroids Market. The report provides an in-depth anatomy of the market trends affecting its growth. Moreover, it includes intricate insights on profitability graph, market share, SWOT analysis and geographical augmentation of this business. Furthermore, the report provides information on the status of key market players in the competitive landscape analysis of this market.

The Topical Corticosteroids market is projected to achieve significant growth by the end of the forecast period as per the research study conducted by FutureWise research analysts. The report explains that this business is predicted to record a remarkable growth rate over the forecast period. This report provides important information regarding the total valuation that this industry holds presently and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Topical Corticosteroids market are    
• AstraZeneca plc
• GlaxoSmithKline plc
• Merck & Co., Inc.
• Pfizer Inc.
• Sandoz AG (Novartis AG)
• Sanofi S.A.
• Actimis Pharmaceuticals
• Valeant Pharmaceuticals
• Almirall, S.A
• Zylera Pharmaceuticals
(Note: The list of the major players will be updated with the latest market scenario and trends)

Topical Corticosteroids Market Segmentation:

By Molecule Name

• Fludroxycortide
• Triamcinolone Acetonide
• Fluocinolone Acetonide
• Antiseptics
• Betamethasone
• Clobetasone Propionate
• Clobetasone Butyrate
• Halobetasone
• Mometasone
• Others

By Application

• Acne
• Dermatitis
• Psoriasis
• Skin Infection
• Hyperpigmentation
• Melasma
• Others

By Medication Type

• Ointments
• Creams
• Liquid & Solutions
• Lotions
• Gel
• Oils
• Pastes
• Sprays
• Others

By End User

• Hospital
• Dermatology Clinics
• Homecare
• Others

By Distribution Channel

• Hospital Pharmacies
• Pharmacy Stores
• Online Pharmacies
• Others

By Region
• North America
• Europe
• Asia-Pacific
• Rest of the world

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Topical Corticosteroids market by molecule name, by application, by medication type, end user, by distribution channel and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
• To record and evaluate the competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
          1.1. Objectives of the Study 
          1.2. Market Definition 
          1.3. Market Scope 
                 1.3.1. Years Considered for the Study
                 1.3.2. Market Covered
          1.4. Currency 
          1.5. Limitations 
          1.6. Stakeholders 
 2.  Research Methodology 
          2.1. Research Data 
                 2.1.1. Secondary Data
                          2.1.1.1. Key Data from Secondary Sources
                 2.1.2. Primary Data
                          2.1.2.1. Key Data from Primary Sources
          2.2. Market Size Estimation 
          2.3. Market Breakdown and Data Triangulation 
          2.4. Assumptions for the Study  
3. Executive Summary
          3.1. Market Outlook
          3.2. Segment Outlook
          3.3. Competitive Insights
4. Global Topical Corticosteroids Market Variables, Trends & Scope
          4.1. Market Lineage Outlook
          4.2. Penetration and Growth Prospect Mapping
          4.3. Industry Value Chain Analysis
          4.4. Cost Analysis Breakdown
          4.5. Technology Overview
          4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Global Topical Corticosteroids Market Overview
          5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Topical Corticosteroids Market Analysis Tools
          6.1. Industry Analysis - Porter’s
                  6.1.1. Supplier Power
                  6.1.2. Buyer Power
                  6.1.3. Substitution Threat
                  6.1.4. Threat from New Entrants
                  6.1.5. Competitive Rivalry
          6.2. Pestel Analysis
                  6.2.1. Political Landscape
                  6.2.2. Environmental Landscape
                  6.2.3. Social Landscape
                  6.2.4. Technology Landscape
                  6.2.5. Legal Landscape
          6.3. Major Deals And Strategic Alliances Analysis
                  6.3.1. Joint Ventures
                  6.3.2. Mergers and Acquisitions
                  6.3.3. Licensing and Partnership
                  6.3.4. Technology Collaborations
                  6.3.5. Strategic Divestments
          6.4. Market Entry Strategies
          6.5. Case Studies
7. Global Topical Corticosteroids Market, By Molecule Name Historical Analysis and Forecast 2020-2027 (USD Million)
          7.1. Fludroxycortide
          7.2. Triamcinolone Acetonide
          7.3. Fluocinolone Acetonide
          7.4. Antiseptics
          7.5. Betamethasone
          7.6. Clobetasone Propionate
          7.7. Clobetasone Butyrate
          7.8. Halobetasone
          7.9. Mometasone
          7.10. Others
8. Global Topical Corticosteroids Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
           8.1. Acne
           8.2. Dermatitis
           8.3. Psoriasis
           8.4. Skin Infection
           8.5. Hyperpigmentation
           8.6. Melasma
           8.7. Others
9. Global Topical Corticosteroids Market, By Medication Type Historical Analysis and Forecast 2020-2027 (USD Million)
           9.1. Ointments
           9.2. Creams
           9.3. Liquid & Solutions
           9.4. Lotions
           9.5. Gel
           9.6. Oils
           9.7. Pastes
           9.8. Sprays
           9.9. Others
10. Global Topical Corticosteroids Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
           10.1. Hospital
           10.2. Dermatology Clinics
           10.3. Homecare
           10.4. Others
11. Global Topical Corticosteroids Market, By Distribution Channel Historical Analysis and Forecast 2020-2027 (USD Million)
           11.1. Hospital Pharmacies
           11.2. Pharmacy Stores
           11.3. Online Pharmacies
           11.4. Others
12.  North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
           12.1. Introduction
           12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                     12.2.1. U.S.A
                     12.2.2. Canada
                     12.2.3. Mexico
           12.3. Market Size (USD Million) Forecast for North America 2020-2027
13. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
           13.1. Introduction
           13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                     13.2.1. Brazil
                     13.2.2. Venezuela
                     13.2.3. Argentina
                     13.2.4. Rest of Latin America
           13.3. Market Size (USD Million) Forecast for Latin America 2020-2027
14. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
           14.1. Introduction
           14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                     14.2.1. Germany
                     14.2.2. U.K
                     14.2.3. France
                     14.2.4. Italy
                     14.2.5. Spain
                     14.2.6. Russia
                     14.2.7. Poland
                     14.2.8. Switzerland
                     14.2.9. Rest of Western Europe
15. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
           15.1. Introduction
           15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                     15.2.1. Japan
                     15.2.2. China
                     15.2.3. Singapore
                     15.2.4. India
                     15.2.5. Australia and New Zealand
                     15.2.6. ASEAN
                     15.2.7. South Korea
                     15.2.8. Rest of Asia Pacific
           15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
           16.1. Introduction
           16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                     16.2.1. Saudi Arabia
                     16.2.2. UAE
                     16.2.3. South Africa
                     16.2.4. Egypt
           16.3. Market Size (USD Million) Forecast for MEA 2020-2027           
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
           17.1. AstraZeneca plc
                     17.1.1. Company Overview
                     17.1.2. Product Portfolio
                     17.1.3. SWOT Analysis
                     17.1.4. Financial Overview
                     17.1.5. Strategic Overview
           17.2. GlaxoSmithKline plc
                     17.2.1. Company Overview
                     17.2.2. Product Portfolio
                     17.2.3. SWOT Analysis
                     17.2.4. Financial Overview
                     17.2.5. Strategic Overview
           17.3. Merck & Co., Inc.
                     17.3.1. Company Overview
                     17.3.2. Product Portfolio
                     17.3.3. SWOT Analysis
                     17.3.4. Financial Overview
                     17.3.5. Strategic Overview
           17.4. Pfizer Inc
                     17.4.1. Company Overview
                     17.4.2. Product Portfolio
                     17.4.3. SWOT Analysis
                     17.4.4. Financial Overview
                     17.4.5. Strategic Overview
           17.5. Sandoz AG (Novartis AG)
                     17.5.1. Company Overview
                     17.5.2. Product Portfolio
                     17.5.3. SWOT Analysis
                     17.5.4. Financial Overview
                     17.5.5. Strategic Overview
           17.6. Sanofi S.A.
                     17.6.1. Company Overview
                     17.6.2. Product Portfolio
                     17.6.3.  SWOT Analysis
                     17.6.4. Financial Overview
                     17.6.5. Strategic Overview
           17.7. Actimis Pharmaceuticals
                     17.7.1. Company Overview
                     17.7.2. Product Portfolio
                     17.7.3. SWOT Analysis
                     17.7.4. Financial Overview
                     17.7.5. Strategic Overview
           17.8. Valeant Pharmaceuticals
                     17.8.1. Company Overview
                     17.8.2. Product Portfolio
                     17.8.3. SWOT Analysis
                     17.8.4. Financial Overview
                     17.8.5. Strategic Overview
           17.9. Almirall, S.A
                      17.9.1. Company Overview
                      17.9.2. Product Portfolio
                      17.9.3. SWOT Analysis
                      17.9.4. Financial Overview
                      17.9.5. Strategic Overview
           17.10. Zylera Pharmaceuticals
                      17.10.1. Company Overview
                      17.10.2. Product Portfolio
                      17.10.3. SWOT Analysis
                      17.10.4. Financial Overview
                      17.10.5. Strategic Overview
18. FutureWise SME key takeaway points for Client

Tables

Figures